ACCESS Newswire

Corsair group

Share
Corsair Signs Deal to Supply Shell with Pyrolysis Oil

BANGKOK, THAILAND / ACCESSWIRE / February 11, 2024 / Plastic waste recycling firm Corsair Bangkok Company Ltd (CORSAIR) has signed a deal to supply Shell Singapore Pte Ltd (SSPL) with pyrolysis oil, a mixed plastic waste feedstock.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

Under the deal, Corsair, a company that converts daily household plastic waste into pyrolysis advanced bio oil, will deliver pyrolysis oil from its plastic waste chemical recycling facility in Thailand to the Shell Energy and Chemicals Park Singapore on Bukom.

The pyrolysis oil will then be used to manufacture sustainable circular chemicals which are typically used in a wide variety of products found in everyday life like cleaning products, textiles, food packaging and others.

The CEO of Corsair, Mr. Jussi Veikko Saloranta said, "We are very excited about this collaboration with Shell.

Plastic waste is a major global problem. From the hundreds of billions of kilos of plastic waste generated around the world annually, less than 10% is estimated to be recycled at this present time. We must do all we can to develop efficient ways for recycling the old, discarded plastic garbage into new plastic products - exactly as what's been done with metals, glass and paper. Burning the plastic in incinerators or dumping it into the landfills is not a solution - the right way is to turn the old plastic back into new plastic products.

Corsair, which started its operations in Thailand and has recently expanded into Europe, has a target to expand Internationally for a greater positive impact on the environment", Saloranta said.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

"At Shell, we believe chemical recycling offers a valuable and viable way to complement mechanical recycling measures, and is needed to achieve the higher recycling rates that are a must for the reduction of waste plastic into the environment. It is not just a partnership for innovation, but a commitment to a sustainable and circular future," said Phil Turley, General Manager of Global Plastic Circular Economy at Shell.

About CORSAIR:

Corsair Group is an international, ISCC certified plastic waste recycling company, which turns daily household plastic waste, such as plastic bags, wrapping materials and packaging products into Advanced Bio-oil at its facilities in Thailand and Finland.

With its Global Head Office located in Thailand and its European Head Office in the Netherlands, Corsair is on a mission to clean our planet from the plastic pollution, by recycling discarded plastic waste from the environment and landfills, into valuable products.

As its global development plan, Corsair aims to expand its plastic waste chemical recycling facilities globally, with its main focus on Asia, Europe and North America.

Additionally to its industrial operations as a plastic waste recycler, Corsair is also the developer and issuer of the world's leading plastic waste offset program, the CSR Plastic Credit. Through the CSR Plastic Credit, Corsair helps businesses and individuals to reduce and remove the impact their plastic waste has on the environment, by becoming Certified Plastic Neutral.

For more information, please visit www.corsairgroup.com

Contact Info
mail: agostino@corsairnow.com
phone: +66 957 613 702

SOURCE: Corsair group



View the original press release on accesswire.com

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen

Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release

SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan

Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release

On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI

PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T

Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release

Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye